Jobs / United States / Glaxosmithkline LLC
Director, US Real-World Evidence and Health Outcome Research
Glaxosmithkline LLC · 🇺🇸 2 Locations
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Glaxosmithkline LLC paid sponsored hires in similar roles4 certified filings for “Associate Director – Genomic Technologies” (Molecular and Cellular Biologists) in PA: $134k–$138k, median $136k. Most were filed at wage level IV (50%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Glaxosmithkline LLC
The US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Glaxosmithkline LLC →
About the role
Position Summary This role will serve as the US Real-World Evidence and Health Outcomes Research (RWE&HOR) lead dedicated to supporting GSK’s oncology hematology portfolio. Reporting to the Hematology Lead within the US RWE/HO Oncology team, this individual will lead RWE generation and support potential new indication launches in the US. RWE&HOR research for hematology and potential new indication launches in in the US. Lead high-priority RWE/HO studies supporting hematology and potential new indication launches in the US. Lead Value Evidence and Strategy Team (VEST) meetings, aligning cross-functional stakeholders on evidence priorities, strategy, and execution. You will be accountable to conduct RWE&HOR research by aligning across cross-functional stakeholders. The successful candidate will have a proven record of health economics and outcomes research strategy development and execution, leadership and research goal attainment. This is a highly visible and strategically important role for GSK. We are looking for an inspiring health economics and outcomes research leader and highly experienced researcher who can lead the way. Responsibilities This role will provide YOU the opportunity to lead key activities to progress YOUR career. These responsibilities include some of the following: RWE&HOR Research • Responsible for ensuring strategic alignment with key internal stakeholders (US medical, commercial, market access, and Global RWE/HOR, Global medical affairs and market access) • Responsible for the management of vendors in execution of HEOR projects. • Working with the study delivery leads by maintaining a budget spreadsheet along with study timelines. • Responsible for ensuring that RWE&HOR research studies (e.g., retrospective database or chart review; meta-analysis/indirect comparison, prospective longitudinal, health economic models, post-hoc analyses) are executed and tracked appropriately. • Develop and maintain strong alignment with the Field Based Payer Medical Teams to obtain insights from the external customers. Adjust plans accordingly to support reimbursement and access for GSK products. • Apply negotiation skills internally and externally to ensure the value of HEOR evidence is used to maximum advantage for GSK products. Why You? Basic Qualifications: We are seeking professionals with the following required skills and qualifications to help us achieve our goals: • MS or PhD in health economics and outcomes research or related discipline (economics, sociology, epidemiology, other) • 3 + years’ experience within the pharmaceutical industry including field research facing role, or related field within US Oncology experience. • Strong cross-functional leadership and stakeholder management skills, with the ability to negotiate and clearly communicate the value and need for real-world evidence to key external Oncology customers. • Experience developing and executing RWE&HOR research and real world data plan by aligning both with internal and external stakeholders. • Designing publication plans and having a presence RWE&HOR studies at major clinical congresses. • Experience managing multiple projects simultaneously. Preferred Qualifications: If you have the following characteristics, it would be a plus: • Knowledge and experience with managing real world evidence including evaluating real world data sources. • Knowledge and experience with appropriate study designs and methods. • Experience working with US customers to build long term relationships to conduct RWE&HOR research. • Knowledge and understanding of requirements for protocol development, disclosure and publication of real-world evidence. • Strong understanding of US healthcare system, payer evidence needs, value demonstration, reimbur